US Pharma MarketingTouting $529B in savings over 10 years, White House looks to expand MFN deals with pharma
Touting $529B in savings over 10 years, White House looks to expand MFN deals with pharma is a pharma and life sciences industry update from FiercePharma. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Following a series of “most favored nation” pricing deals with 17 large pharma companies, the Trump administration released a report Tuesday projecting potential $529 billion in savings from the policy over the next 10 years.
Source: FiercePharma